-
2009
Company Description
Aros Pharma ApS develops therapies for reducing the pain associated with Irritable Bowel Syndrome (IBS)
Aros Pharma is developing a new effective therapy reducing the pain associated with Irritable Bowel Syndrome (IBS). The company has acquired all rights to a new chemical entity that can negatively modulate the activity of acid sensors in the gastrointestinal tract. These acid sensors are believed to play a central role in pain associated with IBS.
-
Manufacturer:
Software -
Formed:
2009 -
Company Website:
-
Company E-mail:
-
Company Address:
Ole Maaløesvej 3, Copenhagen NCopenhagenDenmark -
CEO:
- Henrik Blou
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits